Key result
Focal pulsed field ablation with minimal sedation achieves 100% CTI block in high-risk patients.
Why the study?
In patients with severe COPD or morbid obesity and typical right atrial flutter, the risk of prolonged analgosedation often delays catheter ablation of the cavotricuspid isthmus, leading to repeated electrical cardioversions rather than definitive arrhythmia control.
Does focal pulsed field ablation of the cavotricuspid isthmus combined with an ultra-minimal analgosedation protocol achieve acute bidirectional block and maintain sinus rhythm safely in high-sedation-risk patients with isolated typical right atrial flutter?
Case Report (n=4)
Does focal pulsed field ablation of the cavotricuspid isthmus combined with an ultra-minimal analgosedation protocol achieve acute bidirectional block and maintain sinus rhythm safely in high-sedation-risk patients with isolated typical right atrial flutter?
Combining focal pulsed field ablation with an ultra-minimal, rapidly reversible analgosedation protocol is a feasible and safe strategy to achieve acute CTI block and short-term rhythm control in patients with typical atrial flutter at high risk for sedation complications.
Answers are grounded in this paper and cite their sources.
Supports feasibility of ultra-short sedation for CTI ablation in high-risk patients; hypothesis-generating and requires prospective validation before adoption.
Background Catheter ablation of the cavotricuspid isthmus (CTI) is the guideline-recommended curative treatment for typical right atrial flutter. In patients with severe chronic obstructive pulmonary disease (COPD) or morbid obesity—conditions that frequently underlie isolated typical atrial flutter—the risk of prolonged analgosedation often introduces clinical hesitation regarding ablation referral, frequently resulting in repeated electrical cardioversion rather than definitive arrhythmia control. We report a tailored procedural workflow that leverages the rapid energy delivery of focal pulsed field ablation (PFA) to enable an ultra-minimal, rapidly reversible analgosedation protocol—restricting systemic sedation strictly to the brief period of energy delivery. Case Summary Four male patients with isolated typical right atrial flutter and high sedation risk—due to COPD GOLD III–IV, morbid obesity (BMI up to 40.2 kg/m2), or both—underwent CTI ablation using the FARAPOINT™ focal PFA catheter (Boston Scientific) integrated with the OPAL HDx mapping system. All procedures were initiated under local anaesthesia only. Midazolam (0.5 mg/10 kg body weight), fentanyl (50 µg), and glyceryl trinitrate (2 mg i.v.) were administered immediately prior to the first energy delivery. Bidirectional CTI block was achieved in all patients. Analgosedation was immediately reversed with flumazenil (0.5–1.0 mg) and naloxone (0.4 mg) upon completion of ablation. Mean total analgosedation duration was 7.7 ± 2.9 minutes (range 4:38–11:22 min:sec). Mean procedure duration was 36.5 ± 7.9 minutes; mean fluoroscopy time was 2.8 ± 0.3 minutes. No sedation-related or procedural complications occurred. All patients maintained sinus rhythm through hospital discharge and at follow-up (range 5–12 weeks). Discussion Integrating focal PFA with an ultra-minimal analgosedation protocol demonstrated procedural feasibility and acute CTI block in high-sedation-risk patients. While initial freedom from flutter recurrence during short-term follow-up is encouraging, larger controlled trials with long-term follow-up are required to evaluate durable efficacy and directly compare this strategy with conventional radiofrequency ablation.
No takes yet. Share an insight, caveat, or question.
Masing et al. (2026) conducted a case report in Isolated typical right atrial flutter (n=4). Cavotricuspid isthmus ablation using the FARAPOINT focal pulsed field ablation catheter with an ultra-minimal analgosedation protocol was evaluated on Bidirectional cavotricuspid isthmus block and freedom from flutter recurrence. Focal pulsed field ablation with ultra-minimal analgosedation achieved bidirectional CTI block and sinus rhythm at 5–12 weeks in 100% (4/4) of high-risk patients with a mean sedation time of 7.7 min.
Synapse has enriched 10 related papers. Consider them for comparative context: